Scarica l'app Stockscreener
85.67
1.41%
1.19
Dopo l'orario di chiusura:
85.67
Precedente Chiudi:
$84.48
Aprire:
$84.54
Volume 24 ore:
330.73K
Relative Volume:
0.88
Capitalizzazione di mercato:
$4.23B
Reddito:
$1.11B
Utile/perdita netta:
$205.95M
Rapporto P/E:
20.84
EPS:
4.11
Flusso di cassa netto:
$254.64M
1 W Prestazione:
-0.09%
1M Prestazione:
+4.56%
6M Prestazione:
+1.06%
1 anno Prestazione:
+36.42%
Intervallo 1D:
$84.15
$86.19
Intervallo di 1 settimana:
$83.82
$86.76
Portata 52W:
$62.43
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Nome
Prestige Consumer Healthcare Inc
Settore
Telefono
(914) 524-6800
Indirizzo
660 WHITE PLAINS RD., TARRYTOWN, NY
Confronta PBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
85.67 | 4.24B | 1.11B | 205.95M | 254.64M | 4.11 |
|
HLN
Haleon Plc Adr
|
11.35 | 50.14B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
168.63 | 72.38B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.79 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 45.51B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.45B | 16.54B | -1.64B | 749.00M | -1.45 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-09 | Downgrade | Sidoti | Buy → Neutral |
| 2024-06-21 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2022-11-17 | Iniziato | Canaccord Genuity | Buy |
| 2022-05-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-05-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-06-29 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-04-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-04-07 | Ripresa | Sidoti | Neutral |
| 2020-03-26 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-24 | Iniziato | Oppenheimer | Perform |
| 2020-03-19 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2019-01-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Aggiornamento | Jefferies | Underperform → Hold |
| 2017-05-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Reiterato | B. Riley & Co. | Buy |
| 2016-11-17 | Iniziato | Gabelli & Co | Buy |
| 2016-08-12 | Aggiornamento | Sidoti | Neutral → Buy |
| 2016-03-08 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Iniziato | Piper Jaffray | Overweight |
| 2015-11-30 | Downgrade | Jefferies | Hold → Underperform |
| 2014-04-28 | Reiterato | B. Riley & Co. | Buy |
| 2014-04-28 | Reiterato | Oppenheimer | Outperform |
| 2013-07-09 | Iniziato | B. Riley & Co. | Buy |
Mostra tutto
Prestige Consumer Healthcare Inc Borsa (PBH) Ultime notizie
Equities Analysts Set Expectations for PBH Q1 Earnings - Defense World
Cetera Investment Advisers Invests $413,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
The Sandlot Star Patrick Renna Teams Up with Dramamine® to Revisit an Iconic SceneThis Time, Puke Free - The Malaysian Reserve
Lice Treatment Market Deep Research Report Identifies Key TrendsPrestige Consumer Healthcare, Reckitt - openPR.com
Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock? - Nasdaq
Prestige Consumer Healthcare Inc. (NYSE:PBH) Holdings Decreased by Nuveen Asset Management LLC - Defense World
Deutsche Bank AG Purchases 14,929 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Position Reduced by Ameriprise Financial Inc. - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Upgraded to “Buy” at StockNews.com - Defense World
Weekly Recap: 14 Health Press Releases You Need to See - Yahoo Finance
Prestige's Diversified Portfolio and Strong Execution Should Drive Steady Growth Across Categories - Morningstar
Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase - MSN
U.S. News Announces the 2025-2026 Best OTC Medicine & Health Products - Morningstar
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2025 Earnings Call Transcript - Insider Monkey
How To Trade (PBH) - news.stocktradersdaily.com
Prestige Consumer Healthcare’s Earnings Call Highlights Growth Amid Challenges - TipRanks
Aussie Stocks Hold Steady With US-China Trade Optimism - Finimize
Prestige Consumer Healthcare (NYSE:PBH) Cut to “Hold” at StockNews.com - Defense World
Prestige Consumer Healthcare Full Year 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by Royal Bank of Canada - Defense World
Jefferies raises Prestige Brands target to $85, maintains Hold rating By Investing.com - Investing.com India
Decoding Prestige Consumer Healthcare Inc (PBH): A Strategic SWO - GuruFocus
Saline Nasal Spray Market to See Ongoing Evolution | Major Giants Pfizer Inc,Bayer AG,Novartis AG - newstrail.com
Jefferies raises Prestige Brands target to $85, maintains Hold rating - Investing.com
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Reasonably Well - simplywall.st
Prestige Consumer Healthcare Inc. SEC 10-K Report - TradingView
Prestige Consumer Healthcare Reports Record Fiscal 2025 Results - TipRanks
Prestige Consumer Healthcare: Fiscal Q4 Earnings Snapshot - Greenwich Time
Prestige Consumer Healthcare Q4 2025 Earnings Call Transcript - MarketBeat
Transcript : Prestige Consumer Healthcare Inc., Q4 2025 Earnings Call, May 08, 2025 - marketscreener.com
Prestige: Diversified Portfolio and Strong Execution Drive Steady Growth Across Categories - Morningstar
Premium Brands Holdings (PBH) Target Price Raised by Scotiabank - GuruFocus
Prestige Consumer Healthcare (PBH) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Prestige Consumer Healthcare to Seek M&A - marketscreener.com
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | PBH Stock News - GuruFocus
Prestige Consumer Healthcare Inc. Q4 Profit Increases, Beats Estimates - Nasdaq
Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings - Bluefield Daily Telegraph
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Rev - GuruFocus
Prestige Consumer (PBH) Reports Strong Q4 Revenue and Earnings Growth | PBH Stock News - GuruFocus
Prestige Consumer Healthcare Reports Record Fiscal Year Revenue - TipRanks
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings - The Manila Times
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings | PBH Stock News - GuruFocus
Earnings Flash (PBH) Prestige Consumer Healthcare Posts Q4 Revenue $296.5M, vs. FactSet Est of $291.1M - marketscreener.com
Prestige Consumer Healthcare Inc. Provides Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Prestige Consumer Healthcare Inc (PBH) Q4 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Insights Into Prestige Consumer Healthcare (PBH) Q4: Wall Street Projections for Key Metrics - Yahoo Finance
Prestige Consumer Healthcare Inc Azioni (PBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
18.36%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):